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Abstract The impact of infection by the low-virulent
ASFV/NH/P68 (NHV) and the highly virulent ASFV/L60
(L60) isolates on porcine macrophages was assessed
through the quantification of IFNa, TNFa, IL12p40, TGFb
and ASFV genes by real-time PCR at 2, 4 and 6 h post-
infection. Increased IFNa, TNFa and IL12p40 expression
was found in infection with NHV, in which expression of
TGFb was lower than in infection with L60. Principal
component analysis showed a positive interaction of
cytokines involved in cellular immune mechanisms,
namely IFNa and IL12p40 in the NHV infection. Quanti-
fication by ELISA confirmed higher production of IFNa,
TNFa and IL12p40 in the NHV-infected macrophages.
Overall, our studies reinforce and clarify the effect of the
NHV infection by targeting cellular and cellular-based
immune responses relevant for pig survival against ASFV
infection.
Introduction
African swine fever, first described by Montgomery
[24, 25], is one of the most threatening diseases for pig
husbandry. African swine fever virus (ASFV) is an icosa-
hedral cytoplasmic double-stranded DNA virus which is
the only member of the family Asfarviridae [9]. ASFV
infects all the members of the Suidae family and is non-
pathogenic in its natural hosts, bushpigs (Potamochoerus
porcus) and warthogs (Phacochoerus aetiopicus), which
are kept infected through a natural cycle involving soft
ticks (Ornithodorus moubata) [30, 39]. In domestic pigs,
African swine fever (ASF) may vary from acute to chronic
and unapparent clinical forms in parallel with development
of distinct pathological lesions [31].
ASFV preferentially infects pig monocytes and mac-
rophages, which are the main targets for in vivo viral
replication [5, 6, 14, 15, 20]. In vitro studies demonstrate
that ASFV of different virulence infect and induce lysis of
blood-derived macrophages [4, 11, 20] and bone marrow
and alveolar macrophages [3, 20]. Macrophage infection
by ASFV is of foremost relevance for pathogenesis, tak-
ing into consideration that macrophages play important
roles in both innate and acquired immune responses.
Relevant in the role of macrophages as orchestrators of
immune responses, they synthesize cytokines that have an
impact on the development of inflammatory responses
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(pro-inflammatory cytokines such as IFN type I, IL1, IL6
and TNFa) and cytokines that participate in the develop-
ment of specific immune mechanisms (immunoregulatory
cytokines such as IL12, IL15, IL18) through the activation
of the Th1 and Th2 responses [26].
Previous studies have shown that ASFV inhibits
phagocytosis, antibody-mediated phagocytosis and che-
motaxis in porcine macrophages cultivated in vitro,
although no changes were observed in the expression of Fc
receptors, nor in the capacity to induce antibody-dependent
cytotoxicity (ADCC) [21]. In identical circumstances, the
expression of SLA antigens was not changed on those cells
[13].
Our previous studies using porcine blood-derived
macrophages infected in vitro with two ASFV isolates of
different virulence, the highly virulent L60 and the low-
virulent NHV, demonstrated a particular effect of infec-
tion by the latter isolate in that significantly increased
levels of transcripts for TNFa, IL6, IL12 and IL15 were
identified at 6 hours post-infection, in contrast to the
effect of infection with ASFV/L60 [12]. The differential
expression of those cytokines on macrophages infected
with either ASFV isolate suggests a role of ASFV/NHV in
inducing inflammatory and cellular-based responses in the
natural host, such as the previously described ASFV-
specific CTL activity [22] and NK activity [19]. In the
work reported here, we have extended our previous
studies to evaluate the impact of the infection of porcine
macrophages by the two abovementioned ASFV isolates
in the expression of IFNa, TNFa, IL12p40 (mRNA and
protein) and TGFb (mRNA) at different times post-
infection (2, 4, 6 and 18 h). In parallel, we have assessed
the course of infection through the quantification of the
expression of the ASFV genes VP32, VP72 and A238L
and through the quantification of viral yields at 18 h post-
infection.
Materials and methods
Experimental design
Porcine blood-derived macrophage cultures from seven pig
donors were prepared and infected in vitro with either the
low-virulent ASFV/NH/P68 (NHV), or the highly virulent
ASFV/L60 (L60) at a multiplicity of 3 (MOI = 3), or with
pseudorabies virus (PrV) (used as control of the infection
responses to ASFV). Duplicates of 54 cDNA samples from
individual macrophage cultures collected at 2, 4 and 6 h
post-infection were used to quantify mRNA expression of
the cytokines IFNa, TNFa, IL12p40 and TGFb and the
expression of the ASFV genes A238L, VP32 and VP72.
The characterization of mRNA expression of different
cytokines and viral genes was conducted by quantitative
real-time RT-PCR. Supernatants of macrophage cultures,
collected at 18 h post-infection (overnight incubation) with
the abovementioned virus were used to quantify final
product for IFNa, TNFa and IL12p40 by quantitative
ELISA.
Enriched porcine blood-derived macrophage cultures
and viral infection
Suspensions of peripheral blood mononuclear cells (PBMC)
from seven crossbred Large White 9 Landrace pigs
(6 months old) were prepared from heparinised peripheral
blood samples collected under aseptic conditions during
bleeding at the abattoir, using slight modifications of pro-
tocols described previously [12]. Briefly, heparinised blood
samples were incubated (37C, 15 min), with 10% (v/v) of a
5% (v/v) Dextran T 500 solution in Hank’s balanced saline
solution (HBSS), and supernatants were collected and
centrifuged (400 g, 30 min, room temperature) over Ficoll-
Hypaque (d = 1.077, Seromed). The interface PBMCs
were collected, washed twice and resuspended in complete
culture medium (RPMI 1640 with 100 IU/ml penicillin,
100 lg/ml streptomycin and 20 mM HEPES) supple-
mented with 10% foetal bovine serum (FBS), (Gibco BRL,
102770-106) and seeded in T175 tissue culture flasks
(Nunc, 156502) at 5 9 106 cells/ml. Cultures were incu-
bated (37C, 5% CO2 and [ 90% relative humidity) for
72 h. After incubation, non-adherent cells were removed by
serial washing with pre-warmed phosphate-buffered saline
(PBS) (8 g NaCl, 0.2 g KCl, 1.44 g Na2HPO4, 0.24 g
KH2PO4 per litre, pH 7.4), and adherent macrophages were
harvested by treatment with 0.8 mM EDTA in this buffer.
Cell viability counting by trypan blue dye exclusion
was always [ 90%. Macrophages were re-suspended at
5 9 106/ml in complete culture medium in sterile poly-
propylene centrifuge tubes (Nunc, 366060) and inoculated
with working suspensions of NHV, L60 or PrV at a multi-
plicity of infection of three (MOI = 3). Tubes were kept
horizontal and incubated (37C, 5% CO2 and [ 90% rela-
tive humidity) with slight mechanical shaking for 90 min to
facilitate virus adsorption. Cells were washed, resuspended
in complete culture medium and incubation was continued
for 2, 4, 6, and 18 h. At 2, 4 and 6 h, cells were washed, and
pellets were used for mRNA quantification. Cells incubated
for 18 h were treated similarly and supernatants and pellets
were used to quantify virus yields; supernatants were used
to quantify final products of different cytokines. For all
experiments, non-inoculated macrophages from the same
donors, cultured in complete culture medium, were used as
controls.
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Virus
Two naturally occurring ASFV isolates were used: the
low-virulent non-hemadsorbing ASFV/NH/P68 (NHV) and
the highly virulent ASFV/L60 (L60) [19]. Virus stocks
were grown in blood-derived macrophage cultures as
described previously [21] for no more than six passages.
Supernatants from macrophage cultures infected with stock
virus at an approximate multiplicity of infection of 5
(MOI = 5) were collected when CPE was observed in
more than 80% of cells (around 72 h post-infection),
clarified by centrifugation and further centrifuged over-
night in a GSA rotor at 8,000 g, 4C. Pellets were
suspended (Tris 20 mM, EDTA 1 mM, NaCl 1 M) and re-
sedimented by centrifugation (10,000 g, SW 28 rotor,
Sorvall, 90 min, 4C), through a cushion of 25% sucrose.
The resulting pellet was finally re-suspended in culture
medium. Viral suspensions were titrated by observation of
cytopathic effect (CPE) at end-point dilutions [21]. Sus-
pensions of pseudorabies virus (PrV) were used as clarified
supernatants of Vero cell cultures infected and lysed by the
virus, obtained after an undetermined number of passages
in these cells (kindly supplied by Benedita Cruz, LNIV,
Lisbon, Portugal). Virus titration was performed in Vero
cells as above for ASFV.
RNA extraction
RNA from macrophage cultures was obtained using the
commercial kit ‘‘High Pure RNA extraction kit’’ (ROCHE)
in accordance with the manufacturer’s instructions. The
obtained RNA was dissolved in diethylpyrocarbonate
(DEPC)-treated water and stored at -70C until use.
Samples of RNA were quantified in a spectrophotometer
(DU40 Beckman), at 260 and 280 nm (A). Total RNA was
calculated as described in the literature [33].
Reverse transcription of mRNA into cDNA
Ten lg of total RNA was mixed with oligo (dT)12–18
primers (Gibco BRL, 18064-014) and incubated (70C,
10 min). The mixture was chilled on ice and incubated
(45C, 50 min) with fivefold concentrated reverse trans-
criptase buffer (50 mM Tris–HCl, pH 8.4, 75 mM KCl
(Gibco BRL, 18064-014), 3 mM MgCl2 (Gibco BRL,
18064-014), 500 lM of each deoxynucleotide, 10 mM
dithiothreitol (Gibco BRL, 18064-014) and 200 U of
Superscript II, RT Moloney Murine Leukemia virus
reverse-transcriptase (Gibco BRL, 18064-014). The
reactions were incubated at 90C for 5 min, and the
samples of the cDNA obtained were stored at -20C
until further use.
Primers
Primers for the mRNA amplification of cyclophilin, IFNa,
TNFa, IL12p40, TGF-beta, VP32, VP72 and A238L were
designed using the sequences obtained from the Genebank
Data as the follows:
Cyclophilin (forward—ACGGGTCCTGGCATCTTG
and reverse—AAATGAAAAACTGGGAACCGTTT,
IFNa (forward—CCAGGTCCAGAAGGCTCAAG and
reverse—GCAGCCGAGCCCTCTGT), TNFa (forward—
TGGCCCCTTGAGCATCA and reverse—
ACGGGCTTATCTGAGGTTTGAG),
IL12p40 (forward—CCAAATCTCAGCCAAGGTTA
CAT and reverse—TAGAACCTAATTGCAGGACACA
GATG),
TGFb (forward—AGGACCTGGGCTGGAAGTG and
reverse—GGGCCCCAGGCAGAAAT),
VP32 (forward—TGCACATCCTCCTTTGAAACA T
and reverse—TCTTTTGTGCAAGCATATACAGCTT),
VP72 (forward—ACGGCGCCCTCTAAAGGT and
reverse—CATGGTCAGCTTCAAACGTTTC) and
A238L (forward—GGCCGTACTTCAAATGTGCT and
reverse—CCAGTCCCAAGCAGTAAAGC).
To ensure that amplified cDNA could be distinguished
from any amplified genomic DNA contaminants, each pair
of primers was selected in order to include an intron in the
sequence to be amplified, as determined from sequences
available in Genbank. When porcine sequences were not
available, consensus DNA sequences from other species
were used. Cyclophilin was used as the housekeeping gene
in order to normalize cytokine quantification results. The
choice of cyclophilin was based on previous studies
(unpublished data) in which no differences in the level
of expression of this gene were found on PBMCs from
pigs experimentally inoculated with ASFV of different
virulence.
Plasmids for quantification in RT-PCR
Plasmids for cyclophilin, IFNa, TNFa, TGFb, VP32, VP72
and A238L were obtained as described previously [12].
Colonies of recombinant E. coli were collected and incu-
bated at 37C overnight in suspension with vigorous
shaking in LB broth medium (10 g of Bacto-trypton, 5 g of
yeast-extract and 10 g of NaCl per litre) supplemented with
ampicillin (0.1 mg/ml). Extracted DNA was used for
amplification with the appropriate primers (as described
above) using a conventional PCR machine (Perkin–Elmer)
and sequenced to confirm the identity of the amplicon.
Dilutions of PCR amplicons were quantified by spectro-
photometry [33] and used as standards in real-time PCR
for the quantification of mRNA expression of different
ASFV, regulatory cytokines and porcine macrophages 1847
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cytokines. Quantification of mRNA expression of IL12p40
was assessed using purified amplicons, and the concentra-
tion was calculated as described above.
Optimisation of standard curves for quantification
of cytokine mRNA
Quantification of cyclophilin, IFNa, TNFa, TGFb,
IL12p40, VP32, VP72 and A238L mRNA expression was
assessed by quantitative real-time RT-PCR against the
corresponding standard curves obtained with 101–107 DNA
dilutions of recombinant plasmids (or purified amplicons
for IL12p40). Results of cytokine quantification from
macrophage cultures were expressed as microgram equiv-
alents of the corresponding cytokine standard. The
quantification was obtained with the fluorescence data in
the log-phase portion of the curve, and a crossing line was
set above the level of the noise band to give a value for the
crossing point. The crossing point values of the standards
(plasmids/purified amplicons) at known concentrations
were expressed by a standard curve obtained as a fractional
cycle number determined at the log-phase of the product
amplification, plotted against log concentration, which was
used to determine the concentration in lg of the PCR
products. The melting curves obtained after amplification
were used to verify the specificity of the PCR products/
amplicons by comparison with the melting curves of the
corresponding recombinant plasmids/amplicons.
Viral titration in macrophage supernatants
Supernatants and pellets of macrophage cultures infected
with NHV or L60 obtained at 18 h post-infection were
titrated by observation of cytopathic effect (CPE) at end-
point dilutions as described above [21].
Real-time RT-PCR for mRNA quantification
of cyclophilin, IFNa, TNFa, IL12p40, and TGFb,
in macrophages infected with NHV, L60 or PrV
and VP32, VP72 and A238L in macrophages infected
with NHV or L60
Samples of cDNA were used for mRNA quantification of
cyclophilin, IFNa, TNFa, IL12p40, TGFb, VP32, VP72
and A238L using the Applied Biosystems 7300 Real Time
PCR (Perkin Elmer) following the manufacturer’s
instructions: [12.5 ll of master mix (Power SYBR Green
PCR master mix), Applied Biosystems cat no 4367659,
2.5 ll of forward and reverse primer (50 nM each), 5 ll of
MILLI-Q water and 2.5 ll of cDNA). The cycles for each
run were optimized as follows for cyclophilin, IFNa,
TNFa, TGFb, IL12p40, VP32, VP72 and A238L: 1 cycle
of denaturation (95C for 600 s), 50 cycles of denaturation
(95C for 15 s) and hybridization and extension (60C for
60 s), conditions of final denaturation: 65C for 5 s with
20C/s ramp rate and subsequent heating of the samples to
95C with 0.1C/s ramp rate.
Quantitative enzyme-linked immunosorbent assay
(ELISA) for IFNa, TNFa and IL12p40
Quantitative immunoassay kits were used to measure pro-
tein levels of IFNa (PBL Interferon Source, cat no. 41100),
TNFa and IL12p40 (both from R&D Systems, cat no.
PTA00 and P1240, respectively), following the manufac-
turer’s instructions. Results are shown as the ratio between
values in lg/ml obtained in infected cells and non-infected
control cells.
Expression of results and statistical analysis
The quantification of mRNA expression of the different
genes was obtained as the ratio between the amount of
each cytokine or VP and the amount of the housekeeping
gene (cyclophilin), both in lg. For each group of macro-
phages infected with NHV, L60 and PrV results are shown
as the ratio between the values obtained in infected and
non-infected control cells (C). The validation of the use of
the housekeeping gene was confirmed using the ANOVA
test. Since there are many variables under analysis, a
principal component analysis (PCA) [16] based on the
correlation matrix was performed to assess the overall
mRNA cytokine profile in both viral infections. A princi-
pal component is a linear combination of the original
variables. There are as many principal components as
variables under analysis. For sake of simplicity, we only
analysed the first principal component, which explains
most variability of the data. By interpreting the linear
coefficients of the principal component, one can recognize
which cytokines are more important during infection. The
Wilcoxon signed ranks test for paired samples was used to
compare ELISA results in different viral infections and for
the study of VP (VP32, VP72 and A238L) dynamics. The
significance level was set at 5%. Differences in virus yields
between NHV- and L60-infected macrophages were ana-
lysed using a T test.
Results
Viral titration in infected macrophages
Results of virus titration from supernatants and pellets of
NHV- and L60-infected macrophages are summarized in
Fig. 1. Briefly, yields from supernatants and pellets from
NHV-infected macrophage cultures were higher than in
1848 S. Gil et al.
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L60-infected macrophage cultures (AVG for NHV super-
natants was 5.6 and 4.6 for L60, with P = 0.026, and AVG
for NHV pellets was 5 and 3.7 for L60, with P = 0.025).
Quantification of the expression of IFNa, TNFa,
IL12p40 (mRNA and protein) and TGFb (mRNA)
in macrophages infected with ASFV of different
virulence at different times of infection (2, 4 and 6 h)
using real-time PCR and quantitative ELISA
Porcine blood-derived macrophage cultures from seven pig
donors were prepared and infected in vitro with either the
low-virulent ASFV/NH/P68 (NHV), the highly virulent
ASFV/L60 (L60) at a multiplicity of 3 (MOI = 3) or with
pseudorabies virus (PrV) (used as control for the responses
to ASFV infection). Duplicates of 54 cDNA samples from
individual macrophage cultures collected at 2, 4 and 6 h
post-infection were used to quantify mRNA expression of
the cytokines IFNa, TNFa, IL12p40 and TGFb and the
expression of the ASFV genes A238L, VP32 and VP72.
Their expression was compared to that in non-infected
control cells (C) using a ratio calculation (NHV/C, L60/C
and PrV/C). Results of the mRNA expression of IFNa,
showed an increase of 819 (at 2 h post-infection) and 859
(at 4 h post-infection) in macrophages infected with the
low-virulent NHV in comparison with the control cells. In
macrophages infected with the highly virulent L60 or PrV,
the increase of expression of this cytokine was only evident
at 2 h post-infection (339 and 329, respectively) and
lower than in the NHV-infected macrophages (Table 1A).
mRNA expression of TNFa showed an increase of 1.939
(at 4 h post-infection) and 59 (at 6 h post-infection) in the
macrophages infected with the low-virulent NHV in com-
parison with the control cells. In macrophages infected
with the highly virulent L60 or PrV, the increase of
expression of this cytokine was never higher than 29, even
at 6 h post-infection (Table 1B).
Quantification of the mRNA expression of IL12p40
showed an increase of around 109 (at 2 and 4 h post-
infection) of the mRNA expression of this cytokine in the
macrophages infected with the low-virulent NHV in com-
parison with the control cells. In macrophages infected
with the highly virulent L60, the increase of expression of
this cytokine was never higher than 6.69 (observed at 2 h
post-infection). In PrV-infected macrophages, the mRNA
expression of this cytokine was enhanced 8.49 later in
infection (6 h post-infection) (Table 1C).
mRNA expression of TGFb showed an increase of 29
(at 6 h post-infection) in the macrophages infected with
PrV in comparison with control cells. In macrophages
infected with the highly virulent L60, an increase of
expression (1.69) was observed at 6 h post-infection. The
lower levels of mRNA expression of this cytokine in
comparison with the control values were found in the
NHV-infected macrophages (Table 1D).
Cytokine profiles in both NHV and L60 infections were
assessed by principal component analysis (Table 3). At
2 h post-infection with NHV, the coefficient of TGFb is
close to zero (0.003), which suggests that this cytokine is
not important in the first principal component. The
remaining cytokines have coefficients with the same sign
and similar magnitude. Thus, this principal component
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Fig. 1 Virus titration from supernatants and pellets of NHV- (a) and
L60- (b) infected macrophages cultures from each pig donor (S#).
Titres are expressed as log TCID50
Table 1 Quantification of mRNA expression of IFNa (A), TNFa (B),
IL12p40 (C) and TGFb (D)
NHV/C L60/C PrV/C
A
2 h 81.18 33.18 32.66
4 h 85.40 1.57 2.64
6 h 1.52 1.62 7.89
B
2 h 1.45 1.94 0.86
4 h 1.93 2.08 1.85
6 h 5.03 1.98 1.81
C
2 h 10.3 6.6 5.6
4 h 9.8 1.6 1.6
6 h 1.1 1.1 8.4
D
2 h 0.66 0.93 0.83
4 h 0.75 1.00 1.16
6 h 1.35 1.68 2.29
Relative mRNA expression of the different cytokines is shown as the
ratio between the amount of each cytokine and the amount of the
housekeeping gene (cyclophilin), both in lg. For each group of
infected macrophages with NHV, L60 and PrV at 2, 4 and 6 hours
post-infection, results are shown as the ratio between the values
obtained in infected and non-infected control cells (C) (NHV/C, L60/
C and PrV/C)
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can be interpreted as a sort of mean effect of IFNa, TNFa,
IL12p40 and A238L. At 2 h post-infection with L60,
TGFb has the smallest coefficient, but not as close to zero
as for NHV at the same time point. Since all variables
have coefficients with the same sign and similar values,
this principal component is related to a mean effect of all
variables. At 4 h post-infection with NHV, TGFb, TNFa
and A238L have the highest coefficients in absolute terms.
Since TGFb has a negative coefficient as opposed to
TNFa and A238L, this principal component shows that
TGFb seems to have an opposite effect to TNFa and
A238L. In L60, all variables are important at 4 h post-
infection, because the respective coefficients, are similar
in absolute terms. TGFb, TNFa and IL12p40 show neg-
ative coefficients while IFNa and A238L exhibit positive
coefficient. Therefore, TGFb, TNFa and IL12p40 seem to
have opposite effects to IFNa and A238L. With respect
to 6 h post-infection with NHV, similar results were
obtained to the ones at 4 h. At 6 h post-infection with
L60, the highest coefficients in absolute terms are asso-
ciated with IFNa, TGFb and A238L. Since TGFb has a
negative coefficient as opposed to the IFNa and A238L,
this principal component compares the effects of TGFb to
those of IFNa and A238L.
ELISA results showed a tendency for higher levels in
the protein expression for IFNa in the NHV-infected
macrophage cultures in comparison with the L60-infected
macrophage cultures. By comparison with the control cells
an increase of 0.79 was observed in the NHV infection
(P = 0.02). The higher results obtained for the quantifi-
cation of the IFNa protein at 18 h post-infection were
observed with PrV-infected macrophages (Fig. 2).
The ELISA quantification of TNFa showed an increase
by a factor of 8 and 5 in the supernatants of the macro-
phages infected with NHV and L60, respectively (Table 2)
in comparison with control cells. These increases are sta-
tistically significant (P = 0.02 and 0.03 for NHV and L60,
respectively).
The IL12p40 protein was increased 53.3 and 10 times
in the supernatants of the macrophages infected with
NHV and L60, respectively, in comparison with control
cells (Table 2). Expression of IL12p40 in the NHV
supernatants was significantly higher than in the L60
supernatants (P = 0.03). Lower values of expression of
this cytokine were observed in PrV infection, which
were significantly different from the NHV infection
(P = 0.02).
Quantification of the expression of VP32, VP72 and
A238L in macrophages infected with ASFV of different
virulence at different times of infection (2, 4 and 6 h)
The quantification of mRNA expression of VP32 was
clearly observed at early stages of infection (from 2 h
post-infection) in macrophages infected with both the
low-virulent NHV and the highly virulent L60. Results
showed identical levels of mRNA expression of VP32 at
2 (P = 0.078), 4 (P = 0.578) and 6 (P = 0.625) hours
post-infection in macrophage cultures infected with both
isolates (Fig. 3a). mRNA expression of VP72 and A238L
in the seven macrophage cultures was increased at 4 h
post-infection in macrophages infected with the low-
virulent NHV in comparison with results from macro-
phages infected with L60 (P = 0.016 and P = 0.031,
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Fig. 2 Quantification of the
final product (protein) for IFNa
(a), TNFa (b) and IL12p40 (c)
in macrophage cultures infected
with NH/P68, L60 and PrV. For
each group of macrophages
infected with NHV, L60 and
PrV results are shown as the
ratio between the values
obtained in infected and non-
infected control cells (C) (NHV/
C, L60/C and PrV/C)
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respectively) (Fig. 3b, c). mRNA expression of VP72
and A238L at 2 and 6 h post-infection was identical in
the macrophages infected with both isolates.
Discussion
Depending on the viral isolate, ASFV may induce acute to
chronic, or even unapparent, clinical forms of disease in
domestic pigs, in parallel with the development of distinct
pathological lesions. Different aspects of virus biology may
contribute to this, and during the past decades, several
studies have shown that viral–host interactions are
orchestrated by a complex viral genome, which encodes
more than one hundred proteins, some of which are known
to interfere with or evade host immune responses [8].
Cellular-based immune mechanisms have been demon-
strated to be relevant in protection, as shown in pigs
experimentally inoculated with the low-virulent ASFV/
NH/P68 (NHV), which developed ASFV-specific cytotoxic
T lymphocytes (CTL) activity [17, 18, 22] enhanced nat-
ural killer (NK) cell activity, and survival of challenge with
the highly virulent ASFV/L60 (L60) [19]. More recently,
the role of specific ASFV CTL in protection was further
studied in pigs inoculated the low-virulent OUR/T88/3 and
challenged with the virulent OUR/T88/1 [29]. In this study,
it was demonstrated that pigs exposed to OUR/T88/3 and
then depleted of CD8? lymphocytes were no longer fully
protected against OUR/T88/1 challenge. These results
reinforce the role of CD8? lymphocytes in protective
immunity to ASFV infection.
Macrophage-derived cytokines determine the develop-
ment of inflammatory responses through the expression of
pro-inflammatory cytokines, which are the first defence
against infection, and the induction of specific immune
responses through the expression of immunoregulatory
cytokines. Our previous studies using the L60 and NHV
model of infection of pig macrophages [12] demonstrated
significantly increased levels of transcripts for TNFa, IL6,
IL12 and IL15 in macrophages infected with the low-vir-
ulent virus NHV in comparison to the effect of infection by
L60 at 6 h post-infection.
The studies reported here were conducted to character-
ize the impact of infection in porcine macrophages by
NHV and by L60 on the expression and production of
different cytokines at 2, 4 and 6 h post-infection. At these
different time points, viral infection was assessed through
the quantification of different mRNA expression of viral
proteins VP32, VP72 and A238L, which, except for the
values observed at 4 h post-infection for VP72 and A238L,
were similar in both infections. To better assess the effi-
ciency of infection by each isolate, virus yields obtained at
18 h post-infection, when at least one viral replication
cycle is considered to be completed, have shown higher
progeny levels of NHV in comparison to L60 infection.
To date, little is known about the impact of interferon
type I induction and regulation of ASFV infection. The
Table 2 Statistical analysis of ELISA results of cytokine production
between the different groups tested (control, NHV, L60 and PrV)
using the Wilcoxon signed ranks test
Cytokine P Values (one-tailed)
Friedman test Wilcoxon signed ranks test
IFNa 0.22 NHV-Control 0.02
L60-Control 0.06
PrV-Control 0.22
L60-NHV 0.31
PrV-NHV 0.22
PrV-L60 0.50
IL12 0.06 NHV-Control 0.22
L60-Control 0.31
PrV-Control 0.42
L60-NHV 0.03
PrV-NHV 0.02
PrV-L60 0.41
TNFa 0.0005 NHV-Control 0.02
L60-Control 0.03
PrV-Control 0.34
L60-NHV 0.06
PrV-NHV 0.02
PrV-L60 0.03
VP32 
0 
50000 
100000 
2h 4h 6h 
NHV 
L60 
VP72 
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1 
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c
Fig. 3 Quantification of mRNA expression of VP32 (a), VP72 (b)
and A238L (c) in NHV- and L60-infected macrophage cultures.
Results are show as average ratio ± standard error (AVG ± SE)
between the values in lg of each VP and the values in lg of the
housekeeping gene cyclophilin
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interferon family (IFNs) is one important family of induc-
ible cytokines that stimulate the early or innate antiviral
response to limit viral replication [2, 23]. The multiple
subtypes of a-interferons and the single b-interferon belong
to the type I family of interferons (IFNs), while type II
interferons have a single member: IFN-c [37]. Type I IFNs
have important biological functions, ranging from immune
cell development and activation to tumour cell killing and,
most importantly, inhibition of replication of many RNA
and DNA virus [35]. IFNa and b regulate the homeostatic
differentiation of hematopoietic cells such as B cells, T
cells, osteoclasts, myeloid dendritic cells (DCs) and natural
killer (NK) cells. In the case of immature DCs, their acti-
vation and maturation can be induced by IFNa/b, leading to
the up-regulation of major histocompatibility complex
(MHC) molecules (especially class I MHC), chemokines,
chemokine receptors and costimulatory molecules (CD40,
CD80, CD86), which in turn leads to efficient homing in
secondary lymphoid organs and CD8? and CD4? T cell
responses. In NK cells, IFNa and b increase levels of per-
forin and lead to the induction of cytotoxic activity. T
lymphocyte responses are also modulated through IFNa/b
promotion of Th1 differentiation [37].
In our studies, quantification of IFNa mRNA expression
was conducted in seven cultures of porcine blood-derived
macrophages from different pig donors. The increase of
IFNa mRNA and protein expression compared to control
cells was higher with NHV than with L60. The reasons for
these differences between the two ASFV isolates are not
known. However, recent studies using ASFV with
MGF360/530 deleted [1] demonstrated the implication of
these multigenic families in the transcription inhibition of
the interferon gene and in the interferon activation path-
ways. Other authors using virulent ASFV without these
multigenic families deleted also reported an inhibition in
the IFN transcripts [32, 38, 40, 41]. In contrast to the
presence of those genes in the L60 isolate, NHV virus has a
naturally occurring deletion in the MGF360/530 genes
[10], which could be related to the large enhancement of
IFNa mRNA expression in macrophages infected with the
NHV isolate. Moreover, type I IFNs are potent activators
of anti-viral pathways in infected cells and are strong
inducers of NK cell cytotoxicity, which is well character-
ized in NHV infection [19].
mRNA and protein expression of TNFa was increased in
macrophages infected with the low-virulent NHV in com-
parison with the control cells. In macrophages infected
with the highly virulent L60 or PrV, the increase in
expression of this cytokine was never higher than with
NHV. The increase in the expression of TNFa has already
been demonstrated in our previous studies using the low-
virulent NHV virus [12]. Induction of inflammatory
responses in NHV infection may be regulated through the
enhancement of the expression of this cytokine, which can
activate the cellular immune mechanisms described pre-
viously [19, 22] and may contribute to the protection of the
host against viral infection.
Quantification of the mRNA and protein expression of
IL12p40 showed a higher increase in this cytokine with
NHV compared to L60 and PrV. IL12p40 is a very
important cytokine in the activation of the Th1 lympho-
cytes and in the differentiation of the CD4?/CD8?
subpopulations [36]. The enhancement of this cytokine is
clearly evident in the NHV infection and in accordance
with our previous studies [12]; it may be involved in the
enhancement of T cell proliferation in the development of a
specific CTL and NK response [19, 22] and in the induction
of LAK cells, as reported for NHV infection [34].
An increase of 29 (at 6 h post-infection) in the mRNA
expression of TGFb was observed in macrophages infected
with PrV in comparison with control cells. Lower levels of
the mRNA expression of this cytokine in comparison with
the control values were found in NHV-infected macro-
phages. In macrophages infected with the highly virulent
L60, an increase in expression (1.6 times) was observed at
6 h post-infection. An increase in the expression of the
anti-inflammatory cytokine TGFb was previously reported
in the infection with the virulent ASFV/Malawi/Lil [40].
A principal component analysis was used to clarify the
interpretation of the abovementioned results (Table 3). The
first principal components can be interpreted differently
when analyzing either NHV and L60, or different time
points. This shows that the two viral infections induce
different cytokine profiles. According to this analysis, the
viral protein A238L is very important during both infec-
tions, since it appears in every principal component with a
large (absolute) value. At 2 h post-infection, the role of the
cytokines studied is not well defined for either virus, since
the principal components are a sort of average effect of the
variables. After this time point, some relevant changes are
observed. In the NHV infection, there is somehow a
counteracting effect of TGFb against the expression of
TNFa and A238L at 4 and 6 h post-infection. With respect
Table 3 Assessement of the overall mRNA cytokine expression in
NHV and L60 infection by principal component analysis
Variables 2 h 4 h 6 h
NHV L60 NHV L60 NHV L60
IFNa -0.584 0.538 0.011 0.460 0.137 0.553
TGFb 0.003 0.202 -0.545 -0.411 -0.561 -0.543
TNFa -0.367 0.489 0.580 -0.506 0.514 0.129
IL12p40 -0.525 0.561 -0.157 -0.361 0.390 -0.139
A238L -0.499 0.346 0.585 0.478 0.501 0.603
Var. Exp. % 51.4 55.7 55.5 65.4 51.6 49.7
1852 S. Gil et al.
123
to L60 infection at 4 h, TGFb, TNFa and IL12p40 have an
opposite effect to IFNa and A238L. At 6 h post-infection,
TNFa and IL12p40 seem to loose their relevance in the
course of the infection. More importantly, TGFb appears to
counteract IFNa and A238L expression. From 4 to 6 h, the
difference between cytokine profiles in the L60 infection is
probably related to innate cytokine responses that include
IFN type I, TNFa and IL12p40, which can induce anti-viral
mechanisms in virus-infected cells. Other authors using
lymphocytic choriomeningitis virus [27] have suggested
that it may be important to limit IL12p40 during viral
infections through IFN type I. In fact, even when IL12p40
is observed in early stages of infection, it is only expressed
during a short window of time [28], and interestingly, as
may happen in ASFV infection, its production can be
blocked by IFN type I [7].
Although IFN type I can negatively regulate IL12p40
expression, IL12p40 is also induced in certain viral infec-
tions and is required for the activation of NK cells (2),
which may explain the enhancement of this cellular activity
in the NHV in vivo infections [19].
In conclusion, the NHV isolate induces in porcine
macrophages higher mRNA expression and production of
IFNa, TNFa and IL12p40 and a positive interaction of
cytokines involved in cellular immune mechanisms,
namely IFNa and IL12p40.
Overall, our studies reinforce and clarify the effect of
the NHV infection by targeting cellular and cellular-based
immune responses relevant for pig survival against ASFV
infection.
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